Opioid operant self-administration, analgesia, stimulation and respiratory depression in μ-deficient mice

Psychopharmacology

Volumn 117, Issue 1, 1995, Pages 23-31

  Elmer, Gregory I ^a   Pieper, Jeanne O ^a   Goldberg, Steven R ^a   George, Frank R ^b  

^a NIDA Addiction Research Center   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

CXBK ByJ; Genetics; Opioid; Reinforcement; Self administration

Indexed keywords

BENZIMIDAZOLE; ETONITAZENE; MU OPIATE RECEPTOR; OPIATE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HEREDITY; INBRED STRAIN; INSTRUMENTAL CONDITIONING; LOCOMOTION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR DENSITY; REINFORCEMENT; RESPIRATION DEPRESSION; SELF MEDICATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS; ANIMAL; BENZIMIDAZOLES; CONDITIONING, OPERANT; FEMALE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; MOTOR ACTIVITY; NARCOTICS; PHENOTYPE; RECEPTORS, OPIOID, MU; REINFORCEMENT SCHEDULE; RESPIRATORY MECHANICS; REWARD; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028955603     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02245094     Document Type: Article

References (61)

1. Involvement of central μ and δ opioid receptors in mediating the reinforcing effects of β-endorphin in the rat
2. Opiate receptors in mice: genetic differences
3. A precision drinking device for rats tested with water, etonitazene, and ethanol
4. Studies of genetic differences in response to opioid drugs
5. Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse
6. Inbred strain differences in morphine-induced analgesia with the hot plate assay: a reassesment
7. Where are the μ receptors that mediate opioid analgesia? An autoradiographic study in the HAR and LAR selection lines
8. Reinforcing effect of alfentanil is mediated by μ opioid receptors: apparent pA2 analysis
9. Etonitazene as a reinforcer: Oral intake of etonitazene by rhesus monkeys
10. Intravenous self-administration of etonitazene, cocaine and phencyclidine in rats during food deprivation and satiation
11. Estimation of genetic correlation: Interpretation of experiments using selectively bred and inbred animals
12. Genetic differences in the rewarding and activating effects of morphine and ethanol
13. Genetics of alcoholism and related end-organ damage
14. Mouse strain differences in operant self-administration of ethanol
15. Differential concentration-response curves for oral ethanol self-administration in C57BL/6J and BALB/cJ mice
16. A fixed ratio analysis of oral ethanol reinforced behavior in inbred mouse strains
17. Ethanol self-administration in Long Sleep and Short Sleep mice: evidence for genetic independence of neurosensitivity and reinforcement
18. Genetic factors in conditioned tolerance to the analgesic effects of etonitazene
19. Techniques for assessing the effects of drugs on nociceptive responses
20. Orally delivered cocaine functions as a positive reinforcer in C57BL/6J mice
21. Genetic approaches to the analysis of addiction processes
22. The role of genetics in drug dependence
23. Second-order schedules: extended sequences of behavior controlled by brief environmental stimuli associated with drug self-administration
24. Diazepam self-administration and resistance to extinction
25. Morphine ingestion: genetic control in mice
26. Lipid solubility is correlated with hypnotic and hypothermic responses of Long-Sleep (LS) and Short-Sleep (SS) mice to various depressant drugs
27. Oral etonitazene and cocaine consumption by AA, ANA and Wistar rats
28. Genetic differences in opioid binding and in antinociceptive activities of morphine and ethylketocyclazocine
29. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse
30. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms
31. Strain differences in the magnitude of swimming-induced analgesia in mice correlate with brain opiate receptor concentration
32. Genetic influences on brain stimulation-produced analgesia in mice: II. Correlation with brain opiate receptor concentration
33. The function of schedule-induced polydipsia in establishing ethanol as a positive reinforcer
34. Opioid-like analgesia in defeated mice
35. Genetic analysis of nicotine-induced seizures and hippocampal nicotinic receptors in the mouse
36. Autoradiographic analysis of μ1, μ2, and delta opioid binding in the central nervous system of C57BL/By and CXBK (opioid receptor-deficient) mice
37. Analgesic, locomotor and lethal effects of morphine in the mouse: strain comparisons
38. Strain differences in the effects of morphine on the rectal temperature and respiratory rate in male mice
39. Effects of antagonists selective for μ and δ on the reinforceing effects of heroin in the rat
40. Addiction liability of albino rats: breeding for quantitative differences in morphine drinking
41. Genotype-dependent sensitivity and tolerance to morphine and heroin: dissociation between opiate-induced running and analgesia in the mouse
42. Behavioral effects of opiates: pharmacogenetic analysis
43. Factors that predict individual vulnerability to amphetamine self-administration
44. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains
45. Colonic bead expulsion time in normal and μ-opioid receptor deficient (CXBK) mice folloing central (ICV) administration of μ- and δ-opioid agonists
46. Strain differences in opiate receptors in mouse brain
47. Motivational properties of opioids: evidence that an activation of δ-receptors mediates reinforcement processes
48. Evidence for genetic correlation of hypnotic effects and cerebellar Purkinje neuron depression in response to ethanol in mice
49. Differential establishment and maintenance of oral ethanol reinforced behavior in Lewis and Fischer 344 inbred rat strains
50. Etonitazene delivered orally serves as a reinforcer for Lewis but not Fischer 344 rats
51. Immunomodulatory activity of μ and κ-selective opioid agonists
52. D-Ala2-Methionine-enkephalinamide self-administration in the morphine-dependent rat
53. Examination of the involvement of supraspinal and spinal μ and δ opioid receptors in analgesia using the μ receptor deficient CXBK mouse
54. A psychomotor stimulant theory of addiction
55. Opiates as reinforcing stimuli
56. Correlations among certain behavioral, physiological, and biochemical effects of narcotic agonists
57. Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys